FDA will not regulate most mobile medical appsBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f5841 (Published 26 September 2013) Cite this as: BMJ 2013;347:f5841
- Michael McCarthy
The US Food and Drug Administration will leave most mobile medical applications unregulated while it focuses its oversight on apps that present the greatest risk of harming patients should they not work as intended, the agency said on Monday 23 September.
“Some mobile apps carry minimal risks to consumers or patients, but others can carry significant risks if they do not operate correctly,” said Jeffrey Shuren, director of the FDA’s Center for Devices and Radiological Health, in a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial